相关实验视频
Updated: Jun 28, 2025

04:48
Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
11.0K
对于儿童和青少年的肥胖症:系统审查和元分析
Bin Chen1,2, Zhuan Zou1,2, Xiaoyan Zhang1,2
1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Frontiers in pharmacology
|April 18, 2024
概括
埃克塞纳提德有效降低肥胖儿童和青少年的体重和BMI. 这一对随机对照试验的系统审查发现,埃克西纳提德治疗有益,具有轻微的胃肠道副作用.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 代谢障碍 代谢障碍 代谢障碍
- 临床药理学 临床药理学
背景情况:
- 儿童肥胖缺乏确定的治疗方法,需要有效的治疗策略.
- 作为GLP-1受体激动剂的exenatide正在研究其在治疗儿科肥胖症方面的潜力.
研究的目的:
- 系统地审查随机对照试验 (RCT),评估exenatide在治疗儿童和青少年肥胖症方面的疗效.
- 评估exenatide对体重,BMI和血糖控制的影响,以及安全性和不良事件.
主要方法:
- 在PubMed,科学网,Embase和Cochrane图书馆进行了全面的文献搜索.
- 包括100名儿科参与者的5个RCT,使用Cochrane偏差评估工具进行分析.
- 主要结局包括体重,BMI,空腹血葡萄糖 (FPG) 和HbA1c的变化;不良事件,特别是低血糖症,受到监测.
主要成果:
- 与对照组相比,埃克西纳提德治疗导致体重 (-0.6%) 和BMI (-1.11%) 显著降低.
- 大多数报告的不良事件是轻微的胃肠道症状.
- 没有注意到低血糖症的显著增加.
结论:
- 埃克萨纳提德证明了作为治疗儿科和青少年肥胖症的治疗选择的有效性.
- 进一步的研究可能会探索长期的结果和在这个人群中为exenatide的最佳剂量.
相关概念视频
Glucagon-like Receptor Agonists
319
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
319
Insulin: Dosing Regimen and Adverse Effects
169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169
Obesity
495
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
495
Binge Eating Disorders
63
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
63
Regulation of Food Intake
227
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
227

